Collaborations Pharma, Inc. And Rutgers Announce NIH Award to Develop Treatments for Tuberculosis
Tuesday, August 16, 2016 - 10:31
in Mathematics & Economics
The National Institute of Allergy and Infectious Diseases (NIAID) recently awarded $149,388 to Collaborations Pharma, Inc. (CPI) to initiate a partnership with Rutgers aimed at developing a series of compounds for treating tuberculosis (TB).